Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Shares Outstanding (Diluted Average): 2012-2023

Historic Shares Outstanding (Diluted Average) for Ascendis Pharma A (ASND) over the last 12 years, with Dec 2023 value amounting to $7.0 million.

  • Ascendis Pharma A's Shares Outstanding (Diluted Average) rose 1.77% to $6.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.7 million, marking a year-over-year increase of 1.77%. This contributed to the annual value of $7.0 million for FY2023, which is 0.23% up from last year.
  • According to the latest figures from FY2023, Ascendis Pharma A's Shares Outstanding (Diluted Average) is $7.0 million, which was up 0.23% from $7.0 million recorded in FY2022.
  • Ascendis Pharma A's Shares Outstanding (Diluted Average)'s 5-year high stood at $8.1 million during FY2021, with a 5-year trough of $5.8 million in FY2019.
  • For the 3-year period, Ascendis Pharma A's Shares Outstanding (Diluted Average) averaged around $7.4 million, with its median value being $7.0 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first climbed by 20.61% in 2020, then fell by 13.60% in 2022.
  • Over the past 5 years, Ascendis Pharma A's Shares Outstanding (Diluted Average) (Yearly) stood at $5.8 million in 2019, then climbed by 20.61% to $7.0 million in 2020, then climbed by 15.46% to $8.1 million in 2021, then fell by 13.60% to $7.0 million in 2022, then increased by 0.23% to $7.0 million in 2023.